GO:0051584 regulation of dopamine uptake involved in synaptic transmission: Synaptic Dopamine Clearance, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051584 describes any process that modulates the frequency, rate or extent of the directed movement of dopamine into a cell during synaptic transmission.
• The dopamine transporter (DAT/SLC6A3) is the central protein controlling dopamine reuptake from the synaptic cleft, and its regulation determines the duration and amplitude of dopaminergic signaling.
• Presynaptic autoreceptors, kinases, and trafficking machinery dynamically regulate DAT surface expression and intrinsic transport activity.
• Dysregulation of dopamine uptake is implicated in cocaine sensitization, ischemic stroke injury, depression, and prefrontal cortical dysfunction.
• The vesicular monoamine transporter (VMAT2/SLC18A2) and DAT work together in a VMAT-DAT-dopamine regulatory system that influences neuronal vulnerability.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of genes regulating dopamine uptake.
Description
GO:0051584, regulation of dopamine uptake involved in synaptic transmission, is a biological process term that captures any mechanism modulating the directed movement of the catecholamine neurotransmitter dopamine into a cell. Dopamine is a key neuromodulator in motor control, reward, cognition, and affect, and its signaling is terminated primarily by reuptake through the dopamine transporter (DAT, encoded by SLC6A3). Because the duration and intensity of dopaminergic neurotransmission depend on how quickly dopamine is cleared from the synaptic cleft, the regulation of this uptake process is central to normal brain function and to multiple neurological and psychiatric disorders. Research into GO:0051584 spans molecular, cellular, and systems levels. At the molecular level, DAT activity is regulated by phosphorylation, protein-protein interactions, and substrate-dependent trafficking. At the circuit level, dopamine uptake shapes phasic and tonic signaling that influences approach and avoidance behaviors, as shown in primate studies of dopamine and serotonin neurotransmission. At the disease level, altered dopamine uptake contributes to cocaine sensitization, ischemic stroke pathology, antidepressant responses, and prefrontal cortical network function. Understanding the regulation of dopamine uptake therefore requires integrating transporter biology, vesicular storage, receptor feedback, and disease-relevant signaling cascades. This article provides a research-grade overview of GO:0051584, its key genes, regulatory mechanisms, disease links, and the CRISPR-based models and methods used to study it.
regulation of dopamine uptake involved in synaptic transmission At A Glance
| GO ID | GO:0051584 |
|---|---|
| GO term | regulation of dopamine uptake involved in synaptic transmission |
| Ontology | biological_process |
| Synonym | regulation of dopamine import involved in synaptic transmission |
| Major function | Modulates the frequency, rate or extent of dopamine movement into a cell during synaptic transmission |
| Key transporter | Dopamine transporter (DAT/SLC6A3) mediates reuptake and is a major regulatory target |
| Vesicular partner | VMAT2 (SLC18A2) packages dopamine into vesicles and interacts functionally with DAT |
| Disease relevance | Implicated in cocaine sensitization, ischemic stroke, depression, and prefrontal cortical disorders |
| Research tools | CRISPR knockout, point mutation, knock-in, overexpression, and transporter uptake assays |
What Is GO:0051584?
In simple terms, GO:0051584 is about the control knobs that decide how fast dopamine is pulled back into a cell during synaptic transmission. The QuickGO definition states: any process that modulates the frequency, rate or extent of the directed movement of the catecholamine neurotransmitter dopamine into a cell. This includes changes in transporter abundance at the plasma membrane, transporter activity, and the signaling pathways that adjust dopamine clearance. The synonym regulation of dopamine import involved in synaptic transmission reflects the same concept. The term is a biological_process and is distinct from the uptake itself; it specifically covers the regulatory inputs that tune dopamine reuptake.
Why Is regulation of dopamine uptake involved in synaptic transmission Important in Cell Biology?
GO:0051584 is important because dopamine uptake regulation directly sets the strength and duration of dopaminergic neurotransmission, and its disruption is linked to major human diseases and behavioral disorders. The dopamine transporter is not a static reuptake machine; its surface expression, trafficking, and activity are dynamically controlled by kinases, receptors, and substrates, making it a convergence point for drugs of abuse, antidepressants, and neuroprotective strategies. In ischemic stroke, the VMAT-DAT-dopamine regulatory system has been proposed as a protective target, highlighting the clinical relevance of this process beyond classical neuropsychiatric conditions. In the prefrontal cortex, catecholamine influences on network function depend on precise uptake regulation, which affects working memory and cognitive control. Thus, understanding GO:0051584 is essential for mechanistic neuroscience and for developing targeted therapeutics.
• Controls the duration and amplitude of dopamine signaling at synapses by regulating reuptake.
• Central to the mechanism of action of cocaine and other psychostimulants that target the dopamine transporter.
• Involved in ischemic stroke pathology through the VMAT-DAT-dopamine regulatory system.
• Contributes to antidepressant activity via monoaminergic cross-talk.
• Shapes prefrontal cortical networks underlying cognition and working memory.
• Modulates approach and avoidance behaviors through complementary dopamine and serotonin control.
• Provides a druggable node for neurological and psychiatric disorders.
• Requires precise experimental models such as CRISPR knockouts and knock-ins to dissect causality.
What Happens During regulation of dopamine uptake involved in synaptic transmission?
Dopamine release and the need for clearance
In simple terms: Dopamine is released into the synapse, and something must remove it to stop the signal.
During synaptic transmission, dopamine is released from presynaptic vesicles into the synaptic cleft, where it binds to postsynaptic and presynaptic receptors. To terminate the signal, dopamine must be cleared from the extracellular space, primarily by reuptake into the presynaptic neuron via the dopamine transporter (DAT/SLC6A3). The regulation of this uptake process determines how long dopamine remains available to activate receptors, thereby shaping the temporal profile of neurotransmission. Vesicular packaging by VMAT2 (SLC18A2) also contributes to the overall dopamine handling system, and the VMAT-DAT-dopamine regulatory system has been described as a functional unit.
Dopamine transporter surface expression and trafficking
In simple terms: The number of dopamine transporters on the cell surface is constantly adjusted.
The capacity for dopamine uptake depends on how much DAT is present at the plasma membrane. DAT undergoes constitutive internalization and recycling, and its surface levels are regulated by protein-protein interactions, phosphorylation, and substrate exposure. For example, substrates and blockers can alter DAT trafficking, leading to changes in uptake capacity. This dynamic trafficking is a core component of GO:0051584 because it modulates the rate of dopamine import into the cell.
Kinase and receptor-mediated regulation of DAT activity
In simple terms: Chemical switches inside the neuron can turn dopamine uptake up or down.
DAT activity is regulated by multiple signaling pathways, including protein kinase C and other kinases that can modify transporter trafficking and intrinsic activity. Presynaptic autoreceptors, such as D2 dopamine receptors, provide feedback control over dopamine release and uptake. These regulatory inputs allow the neuron to adapt uptake capacity to changes in firing rate and extracellular dopamine levels. The integration of these signals is central to the biological process defined by GO:0051584.
Vesicular storage and the VMAT-DAT interplay
In simple terms: Dopamine inside the cell is packaged into vesicles, and this packaging is linked to reuptake.
After reuptake, dopamine is either repackaged into synaptic vesicles by VMAT2 or degraded by monoamine oxidase. The VMAT-DAT-dopamine regulatory system highlights the functional coupling between vesicular storage and plasma membrane reuptake. In ischemic stroke models, modulation of this system has been associated with neuroprotective effects, suggesting that coordinated regulation of VMAT and DAT is important for neuronal survival. This interplay adds another layer to the regulation of dopamine uptake involved in synaptic transmission.
Disease-relevant modulation of dopamine uptake
In simple terms: In disease, the normal control of dopamine uptake can go wrong.
Alterations in dopamine uptake regulation have been observed in cocaine sensitization, where cortical mechanisms contribute to persistent behavioral changes. In ischemic stroke, the dopamine transporter has been proposed as a new target, and the VMAT-DAT-dopamine system is involved in protective effects of compounds such as 3-n-butylphthalide. Monoaminergic cross-talk is also relevant to antidepressant activity, where changes in dopamine uptake can influence therapeutic outcomes. These examples illustrate how GO:0051584 connects to human disease.
Key Genes Involved in GO:0051584 regulation of dopamine uptake involved in synaptic transmission
The following genes and proteins are central to the regulation of dopamine uptake involved in synaptic transmission, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC6A3 (DAT) | Primary dopamine transporter mediating reuptake from the synaptic cleft | Core target for uptake assays, trafficking studies, and psychostimulant research |
| SLC18A2 (VMAT2) | Vesicular monoamine transporter packaging dopamine into synaptic vesicles | Component of the VMAT-DAT-dopamine regulatory system in stroke and neuroprotection |
| DRD2 | Dopamine D2 receptor providing presynaptic autoreceptor feedback | Regulates dopamine release and uptake via feedback loops |
| DRD1 | Dopamine D1 receptor mediating postsynaptic signaling | Influences approach and avoidance behaviors in primate models |
| PRKCA | Protein kinase C alpha involved in DAT phosphorylation and trafficking | Modulates DAT surface expression and uptake capacity |
| PRKCB | Protein kinase C beta contributing to DAT regulation | Potential target for modulating dopamine clearance |
| PICK1 | Protein interacting with C kinase 1, regulates DAT trafficking | Studied for its role in transporter internalization |
| SNCA | Alpha-synuclein, interacts with DAT and influences uptake | Linked to Parkinson's disease and dopamine transporter function |
| SLC6A2 (NET) | Norepinephrine transporter with overlapping substrate specificity | Contributes to catecholamine clearance and cross-talk |
| SLC6A4 (SERT) | Serotonin transporter, part of monoaminergic cross-talk | Relevant to antidepressant mechanisms and dopamine-serotonin interactions |
| MAOA | Monoamine oxidase A degrading dopamine after reuptake | Affects intracellular dopamine levels and uptake regulation |
| MAOB | Monoamine oxidase B degrading dopamine | Target for neuroprotection and dopamine modulation |
| COMT | Catechol-O-methyltransferase degrading catecholamines | Influences prefrontal cortical dopamine availability |
| TH | Tyrosine hydroxylase, rate-limiting enzyme in dopamine synthesis | Synthesis and uptake are functionally coupled |
| AADC | Aromatic L-amino acid decarboxylase in dopamine synthesis | Enzyme expressed in non-dopaminergic neurons with functional significance |
| SLC18A1 | Vesicular monoamine transporter 1, related to VMAT2 | Potential compensatory role in vesicular storage |
| GNAI1 | Gi protein subunit involved in D2 receptor signaling | Mediates autoreceptor feedback on uptake |
| ARRB1 | Beta-arrestin 1 regulating DAT internalization | Controls transporter trafficking and uptake capacity |
How Is regulation of dopamine uptake involved in synaptic transmission Regulated?
The regulation of dopamine uptake involved in synaptic transmission is itself regulated at multiple levels. At the transporter level, DAT activity and surface expression are modulated by phosphorylation, protein-protein interactions, and substrate-dependent trafficking. Presynaptic D2 autoreceptors provide feedback inhibition of dopamine release and can influence uptake capacity. Monoaminergic cross-talk, including serotonin and norepinephrine systems, can also affect dopamine clearance and antidepressant responses. In the prefrontal cortex, catecholamine influences on network function depend on precise uptake regulation, which is sensitive to arousal and stress. Additionally, the VMAT-DAT-dopamine regulatory system integrates vesicular storage with plasma membrane reuptake, and its modulation has been linked to neuroprotective effects in ischemic stroke. These layers of regulation ensure that dopamine signaling is dynamically tuned to physiological demands.
regulation of dopamine uptake involved in synaptic transmission and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC6A3 (DAT) | Cocaine sensitization and addiction | DAT knockout and point-mutation models in rodents |
| SLC6A3 (DAT) | Ischemic stroke | Middle cerebral artery occlusion in DAT knockout mice |
| SLC18A2 (VMAT2) | Ischemic stroke neuroprotection | VMAT2 knockout or overexpression in stroke models |
| SLC6A4 (SERT) | Depression and antidepressant response | SERT knockout and monoamine cross-talk models |
| COMT | Prefrontal cortical dysfunction | COMT knockout and prefrontal cognitive tasks |
Cocaine sensitization and addiction
Cocaine sensitization involves persistent changes in cortical mechanisms that regulate dopamine uptake and signaling. The dopamine transporter is a primary target of cocaine, and its regulation is central to the behavioral effects of psychostimulants. Studies of cortical mechanisms of cocaine sensitization have highlighted how alterations in dopamine uptake regulation contribute to addiction-related plasticity. Understanding GO:0051584 is therefore relevant to addiction research and to the development of interventions targeting dopamine clearance.
Ischemic stroke and neuroprotection
The dopamine transporter has been proposed as a new target for ischemic stroke, and the VMAT-DAT-dopamine regulatory system is involved in the protective effect of 3-n-butylphthalide against ischemic stroke. Dysregulation of dopamine uptake can exacerbate excitotoxicity and oxidative stress in the ischemic brain. Modulating this system may offer neuroprotective strategies, making GO:0051584 a clinically relevant process in stroke research.
Depression and monoaminergic cross-talk
Consequences of monoaminergic system cross-talk are relevant to antidepressant activity, and dopamine uptake regulation is part of this interplay. Antidepressants that affect serotonin and norepinephrine systems can indirectly influence dopamine clearance and signaling. This cross-talk underscores the importance of GO:0051584 in mood disorders and in the mechanisms of antidepressant drugs.
Prefrontal cortical dysfunction
Catecholamine influences on dorsolateral prefrontal cortical networks are critical for working memory and cognitive control, and these effects depend on precise regulation of dopamine uptake. Imbalances in dopamine clearance can impair prefrontal network function, contributing to cognitive deficits in stress-related and psychiatric conditions. Thus, GO:0051584 is relevant to understanding prefrontal cortical disorders.
From regulation of dopamine uptake involved in synaptic transmission-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DAT alter dopamine clearance and behavior? | SLC6A3 knockout mouse or rat |
| Does a specific DAT phosphorylation site regulate surface expression? | Point-mutation knock-in of DAT phospho-mutant |
| Does tagging endogenous DAT reveal trafficking dynamics? | Tagged knock-in of SLC6A3 with fluorescent or epitope tag |
| Does overexpression of VMAT2 protect against ischemic injury? | VMAT2 overexpression transgenic model |
| Does D2 autoreceptor feedback regulate uptake capacity? | DRD2 knockout or conditional knockout |
| Does monoaminergic cross-talk affect antidepressant response? | SERT and DAT double knockout models |
How to Study the regulation of dopamine uptake involved in synaptic transmission Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fast-scan cyclic voltammetry | Real-time dopamine release and clearance | Assessing uptake regulation in brain slices |
| Radioligand binding | DAT density and affinity | Characterizing transporter expression changes |
| Uptake assay | Transport activity in cells or synaptosomes | Measuring functional consequences of mutations |
| Immunocytochemistry | DAT surface expression and localization | Studying trafficking regulation |
| Live-cell imaging | Dynamic internalization and recycling | Visualizing transporter movement |
| CRISPR knockout screen | Genes required for dopamine uptake regulation | Unbiased discovery of novel regulators |
| RNA sequencing | Transcriptional changes in dopamine neurons | Identifying pathways linked to uptake regulation |
| Bioinformatics pathway analysis | Enriched pathways and networks | Prioritizing candidate genes for validation |
Fast-scan cyclic voltammetry
Fast-scan cyclic voltammetry measures real-time dopamine release and clearance in brain slices or in vivo, providing direct readouts of uptake regulation. This method is widely used to assess the functional consequences of genetic manipulations in DAT and related genes. It allows researchers to quantify changes in dopamine uptake rate and amplitude.
Radioligand binding and uptake assays
Radioligand binding assays quantify DAT density and affinity, while uptake assays in synaptosomes or transfected cells measure transport activity. These methods are essential for characterizing how mutations or regulatory signals alter dopamine uptake capacity. They can be combined with pharmacological inhibitors to dissect specific contributions.
Immunocytochemistry and live-cell imaging
Immunocytochemistry and live-cell imaging with fluorescently tagged transporters reveal DAT surface expression, internalization, and recycling. These approaches are critical for studying the trafficking component of GO:0051584. They can be applied to primary neurons or heterologous expression systems.
CRISPR-based genetic screens and transcriptomics
CRISPR knockout screens and RNA sequencing can identify genes that regulate dopamine uptake when knocked out or overexpressed. These unbiased approaches can uncover novel regulators of DAT trafficking and activity. Bioinformatics analysis then prioritizes candidate pathways for functional validation.
How CRISPR Can Be Used to Study GO:0051584 regulation of dopamine uptake involved in synaptic transmission
Knockout
CRISPR knockout of SLC6A3 (DAT) or SLC18A2 (VMAT2) creates cell and animal models to study the loss of dopamine uptake regulation. These models are used to measure changes in dopamine clearance, behavior, and disease susceptibility. Knockout of regulatory genes such as PRKCA or ARRB1 can reveal their roles in DAT trafficking.
Point Mutation
Point mutations in DAT phosphorylation sites or substrate-binding residues can be introduced by CRISPR to dissect specific regulatory mechanisms. These models help determine whether a single amino acid change alters uptake capacity or trafficking. They are valuable for linking molecular modifications to functional outcomes.
Knock-in
Knock-in of fluorescent or epitope tags into endogenous SLC6A3 allows real-time visualization of DAT trafficking and localization. Knock-in of disease-associated variants can model human genetic contributions to dopamine uptake dysregulation. These models preserve endogenous regulatory context.
Overexpression
Overexpression of DAT, VMAT2, or candidate regulatory genes can test sufficiency in driving changes in dopamine uptake. Overexpression models are useful for gain-of-function studies and for testing neuroprotective strategies. They complement knockout approaches to establish causality.
How EDITGENE Supports regulation of dopamine uptake involved in synaptic transmission Research
Researchers studying regulation of dopamine uptake involved in synaptic transmission-related genes often need to determine whether a candidate gene is causally involved in transporter trafficking, dopamine clearance, or disease-relevant phenotypes. EDITGENE provides CRISPR-based cell and animal models to enable this causal dissection with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of dopamine uptake involved in synaptic transmission research.
Frequently Asked Questions About regulation of dopamine uptake involved in synaptic transmission
What is GO:0051584?
GO:0051584 is the Gene Ontology term for regulation of dopamine uptake involved in synaptic transmission, defined as any process that modulates the frequency, rate or extent of the directed movement of dopamine into a cell.
What genes are involved in regulation of dopamine uptake involved in synaptic transmission?
Key genes include SLC6A3 (DAT), SLC18A2 (VMAT2), DRD2, PRKCA, PICK1, SNCA, and others that regulate transporter trafficking and activity.
How is dopamine uptake regulated at the synapse?
Dopamine uptake is regulated by DAT surface expression, phosphorylation, protein-protein interactions, and presynaptic autoreceptor feedback.
Why is the dopamine transporter important for dopamine clearance?
DAT is the primary protein that removes dopamine from the synaptic cleft, and its regulation determines the duration and amplitude of dopamine signaling.
What diseases are linked to dopamine uptake dysregulation?
Diseases include cocaine sensitization, ischemic stroke, depression, and prefrontal cortical dysfunction.
How do researchers study dopamine uptake regulation?
Researchers use fast-scan cyclic voltammetry, radioligand binding, uptake assays, imaging, and CRISPR screens.
What is the VMAT-DAT-dopamine regulatory system?
It is a functional system linking vesicular dopamine storage by VMAT2 with plasma membrane reuptake by DAT, implicated in ischemic stroke protection.
Can CRISPR be used to study dopamine uptake genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are used to dissect the roles of DAT and related genes.
What is the role of D2 autoreceptors in dopamine uptake?
D2 autoreceptors provide feedback regulation of dopamine release and can influence uptake capacity.
How does monoaminergic cross-talk affect dopamine uptake?
Serotonin and norepinephrine systems can influence dopamine clearance and are relevant to antidepressant mechanisms.
Conclusion
GO:0051584, regulation of dopamine uptake involved in synaptic transmission, is a fundamental biological process that controls the strength and duration of dopamine signaling. Its dysregulation is implicated in addiction, ischemic stroke, depression, and cognitive disorders, making it a high-priority research area. Advances in CRISPR-based models and functional assays now allow precise causal dissection of the genes and pathways that regulate dopamine uptake. Continued research into this process promises to inform new therapeutic strategies for neurological and psychiatric diseases.
References
- 1. Steketee JD. 2005. Cortical mechanisms of cocaine sensitization.. Crit Rev Neurobiol 17(2):69-86 PMID: 16808728
- 2. German CL et al.. 2015. Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.. Pharmacol Rev 67(4):1005-24 PMID: 26408528
- 3. Ugriumov MV. 2007. [Expression of the enzymes of dopamine synthesis in non-dopaminergic neurons: functional significance and regulation].. Usp Fiziol Nauk 38(4):3-20 PMID: 18064905
- 4. Zhou XT et al.. 2026. VMAT-DAT-Dopamine Regulatory System Involved in the Protective Effect of 3-n-Butylphthalide Against Ischemic Stroke.. CNS Neurosci Ther 32(8):e71094 PMID: 42613797
- 5. Cheng YQ et al.. 2024. The Dopamine Transporter Is a New Target for Ischemic Stroke.. CNS Neurosci Ther 30(10):e70092 PMID: 39467829
- 6. Gauthier L et al.. 2025. Dopamine and serotonin neurotransmissions exert complementary control over primate approach and avoidance.. Transl Psychiatry 16(1):27 PMID: 41461630
- 7. Tritschler L et al.. 2018. [Consequences of the monoaminergic systems cross-talk in the antidepressant activity].. Encephale 44(3):264-273 PMID: 29801770
- 8. Arnsten AF. 2011. Catecholamine influences on dorsolateral prefrontal cortical networks.. Biol Psychiatry 69(12):e89-99 PMID: 21489408
